Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Tick-borne Encephalitis Vaccine Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Tick-borne Encephalitis Vaccine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 European TBE Virus
      • 1.3.3 Far Eastern TBE Virus
      • 1.3.4 Siberian TBE Virus
    • 1.4 Market Segment by Application
      • 1.4.1 Global Tick-borne Encephalitis Vaccine Market Share by Application (2019-2025)
      • 1.4.2 Pediatric Vaccines
      • 1.4.3 Adult Vaccines
      • 1.4.4 Traveler Vaccines
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Tick-borne Encephalitis Vaccine Market Size
      • 2.1.1 Global Tick-borne Encephalitis Vaccine Revenue 2014-2025
      • 2.1.2 Global Tick-borne Encephalitis Vaccine Sales 2014-2025
    • 2.2 Tick-borne Encephalitis Vaccine Growth Rate by Regions
      • 2.2.1 Global Tick-borne Encephalitis Vaccine Sales by Regions 2014-2019
      • 2.2.2 Global Tick-borne Encephalitis Vaccine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Tick-borne Encephalitis Vaccine Sales by Manufacturers
      • 3.1.1 Tick-borne Encephalitis Vaccine Sales by Manufacturers 2014-2019
      • 3.1.2 Tick-borne Encephalitis Vaccine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Tick-borne Encephalitis Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Tick-borne Encephalitis Vaccine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Tick-borne Encephalitis Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Tick-borne Encephalitis Vaccine Price by Manufacturers
    • 3.4 Key Manufacturers Tick-borne Encephalitis Vaccine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Tick-borne Encephalitis Vaccine Market
    • 3.6 Key Manufacturers Tick-borne Encephalitis Vaccine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 European TBE Virus Sales and Revenue (2014-2019)
      • 4.1.2 Far Eastern TBE Virus Sales and Revenue (2014-2019)
      • 4.1.3 Siberian TBE Virus Sales and Revenue (2014-2019)
    • 4.2 Global Tick-borne Encephalitis Vaccine Sales Market Share by Type
    • 4.3 Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type
    • 4.4 Tick-borne Encephalitis Vaccine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Tick-borne Encephalitis Vaccine Sales by Application

    6 United States

    • 6.1 United States Tick-borne Encephalitis Vaccine Breakdown Data by Company
    • 6.2 United States Tick-borne Encephalitis Vaccine Breakdown Data by Type
    • 6.3 United States Tick-borne Encephalitis Vaccine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Tick-borne Encephalitis Vaccine Breakdown Data by Company
    • 7.2 European Union Tick-borne Encephalitis Vaccine Breakdown Data by Type
    • 7.3 European Union Tick-borne Encephalitis Vaccine Breakdown Data by Application

    8 China

    • 8.1 China Tick-borne Encephalitis Vaccine Breakdown Data by Company
    • 8.2 China Tick-borne Encephalitis Vaccine Breakdown Data by Type
    • 8.3 China Tick-borne Encephalitis Vaccine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Tick-borne Encephalitis Vaccine Breakdown Data by Company
    • 9.2 Rest of World Tick-borne Encephalitis Vaccine Breakdown Data by Type
    • 9.3 Rest of World Tick-borne Encephalitis Vaccine Breakdown Data by Application
    • 9.4 Rest of World Tick-borne Encephalitis Vaccine Breakdown Data by Countries
      • 9.4.1 Rest of World Tick-borne Encephalitis Vaccine Sales by Countries
      • 9.4.2 Rest of World Tick-borne Encephalitis Vaccine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer
      • 10.1.1 Pfizer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Tick-borne Encephalitis Vaccine
      • 10.1.4 Tick-borne Encephalitis Vaccine Product Introduction
      • 10.1.5 Pfizer Recent Development
    • 10.2 Encephalitis
      • 10.2.1 Encephalitis Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Tick-borne Encephalitis Vaccine
      • 10.2.4 Tick-borne Encephalitis Vaccine Product Introduction
      • 10.2.5 Encephalitis Recent Development
    • 10.3 Cochrane Collaboration
      • 10.3.1 Cochrane Collaboration Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Tick-borne Encephalitis Vaccine
      • 10.3.4 Tick-borne Encephalitis Vaccine Product Introduction
      • 10.3.5 Cochrane Collaboration Recent Development
    • 10.4 Sonic HealthPlus
      • 10.4.1 Sonic HealthPlus Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Tick-borne Encephalitis Vaccine
      • 10.4.4 Tick-borne Encephalitis Vaccine Product Introduction
      • 10.4.5 Sonic HealthPlus Recent Development
    • 10.5 Superdrug Health
      • 10.5.1 Superdrug Health Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Tick-borne Encephalitis Vaccine
      • 10.5.4 Tick-borne Encephalitis Vaccine Product Introduction
      • 10.5.5 Superdrug Health Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Tick-borne Encephalitis Vaccine Sales Channels
      • 11.2.2 Tick-borne Encephalitis Vaccine Distributors
    • 11.3 Tick-borne Encephalitis Vaccine Customers

    12 Market Forecast

    • 12.1 Global Tick-borne Encephalitis Vaccine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Tick-borne Encephalitis Vaccine Sales Forecast by Type
    • 12.3 Global Tick-borne Encephalitis Vaccine Sales Forecast by Application
    • 12.4 Tick-borne Encephalitis Vaccine Forecast by Regions
      • 12.4.1 Global Tick-borne Encephalitis Vaccine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Tick-borne Encephalitis Vaccine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      The major factors that drive the growth of global tick-borne encephalitis vaccine, inactivated market is rise in prevalence of tick-borne encephalitis, especially in Europe, and increased government funding on healthcare facilities. In addition, increase in drug development owing to technological advancement in the medical sector fuels the market growth. However, high cost of vaccines is the major restraint of the market. On the contrary, untapped economies with unmet medical needs is anticipated to provide lucrative opportunities for market growth.
      In 2019, the market size of Tick-borne Encephalitis Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tick-borne Encephalitis Vaccine.

      This report studies the global market size of Tick-borne Encephalitis Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Tick-borne Encephalitis Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer
      Encephalitis
      Cochrane Collaboration
      Sonic HealthPlus
      Superdrug Health
      ...

      Market Segment by Product Type
      European TBE Virus
      Far Eastern TBE Virus
      Siberian TBE Virus

      Market Segment by Application
      Pediatric Vaccines
      Adult Vaccines
      Traveler Vaccines

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Tick-borne Encephalitis Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Tick-borne Encephalitis Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Tick-borne Encephalitis Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now